Humana Company Profile (NYSE:HUM)

About Humana (NYSE:HUM)

Humana logoHumana Inc. is a health and well-being company. The Company's segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, as well as individual commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products. The Group segment consists of employer group commercial fully insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and voluntary insurance benefits, as well as administrative services only (ASO) products. The Healthcare Services segment includes services offered to its health plan members, as well as to third parties, including pharmacy solutions, provider services, home-based services and clinical programs, as well as services and capabilities to manage population health. The Other Businesses segment includes its closed-block long-term care insurance policies.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Health Care Plans
  • Sub-Industry: Managed Health Care
  • Symbol: NYSE:HUM
  • CUSIP: 44485910
  • Web:
  • Market Cap: $33.51 billion
  • Outstanding Shares: 144,314,000
Average Prices:
  • 50 Day Moving Avg: $222.23
  • 200 Day Moving Avg: $209.51
  • 52 Week Range: $150.00 - $234.87
  • Trailing P/E Ratio: 23.67
  • Foreward P/E Ratio: 19.16
  • P/E Growth: 1.59
Sales & Book Value:
  • Annual Revenue: $54.34 billion
  • Price / Sales: 0.62
  • Book Value: $70.91 per share
  • Price / Book: 3.27
  • Annual Dividend: $1.16
  • Dividend Yield: 0.6%
  • EBIDTA: $2.27 billion
  • Net Margins: 1.09%
  • Return on Equity: 13.09%
  • Return on Assets: 5.21%
  • Debt-to-Equity Ratio: 0.35%
  • Current Ratio: 2.07%
  • Quick Ratio: 1.66%
  • Average Volume: 1.46 million shs.
  • Beta: 0.91
  • Short Ratio: 3.9

Frequently Asked Questions for Humana (NYSE:HUM)

What is Humana's stock symbol?

Humana trades on the New York Stock Exchange (NYSE) under the ticker symbol "HUM."

How often does Humana pay dividends? What is the dividend yield for Humana?

Humana declared a quarterly dividend on Thursday, April 20th. Shareholders of record on Friday, June 30th will be paid a dividend of $0.40 per share on Monday, July 31st. This represents a $1.60 annualized dividend and a yield of 0.69%. The ex-dividend date is Wednesday, June 28th. View Humana's Dividend History.

How will Humana's stock buyback program work?

Humana declared that its Board of Directors has authorized a share repurchase program on Tuesday, April 11th 2017, which authorizes the company to repurchase $2,250,000,000.00 in outstanding shares, according to EventVestor. This repurchase authorization authorizes the company to buy up to 7.3% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's leadership believes its stock is undervalued.

How were Humana's earnings last quarter?

Humana Inc (NYSE:HUM) announced its quarterly earnings data on Wednesday, May, 3rd. The company reported $2.75 earnings per share for the quarter, topping analysts' consensus estimates of $2.55 by $0.20. The company earned $13.76 billion during the quarter, compared to analysts' expectations of $13.61 billion. Humana had a return on equity of 13.09% and a net margin of 1.09%. During the same quarter last year, the firm posted $1.86 earnings per share. View Humana's Earnings History.

When will Humana make its next earnings announcement?

Humana is scheduled to release their next quarterly earnings announcement on Wednesday, August, 2nd 2017. View Earnings Estimates for Humana.

What guidance has Humana issued on next quarter's earnings?

Humana issued an update on its FY17 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share (EPS) guidance of $11.10+ for the period, compared to the Thomson Reuters consensus EPS estimate of $11.15.

Where is Humana's stock going? Where will Humana's stock price be in 2017?

18 equities research analysts have issued 1-year price targets for Humana's shares. Their predictions range from $170.00 to $240.00. On average, they anticipate Humana's share price to reach $212.73 in the next twelve months. View Analyst Ratings for Humana.

What are analysts saying about Humana stock?

Here are some recent quotes from research analysts about Humana stock:

  • 1. According to Zacks Investment Research, "Humana’s continuous margin growth, accretive acquisitions, efficient capital deployment, business diversification initiatives and consistent revenue growth paved the way for long-term growth. The company’s earnings per share of $2.75 beat the Zacks Consensus Estimate and improved 38% year over year, primarily due to the receipt of the break up fee from the terminated merger with Aetna and outstanding performance by the Retail segment. Its strong balance sheet is another positive. In fact, the stock gained 32% as against the Zacks categorized HMO industry’s increase of 30%, in last one year. However, cancellation of the merger with Aetna, which would have solidified its position in the industry, lowered Humana’s face value in the market. Moreover, stiff competition, and weakness in individual commercial business raise concerns." (5/25/2017)
  • 2. Cantor Fitzgerald analysts commented, "We are transferring coverage of Humana (HUM) and rate the shares at Neutral; our 12-month DCF-based price target is $186. The shares trade 6% above our price target, probably due in part to continued speculation that HUM remains a takeover candidate. We believe there is a low probability that AET will successfully appeal a recent court decision which ruled against the merger (if it even decides to appeal the decision). We assign a low probability that HUM will be acquired, at least in the short term. HUM's losses relating to the Affordable Care Act will shrink in 2017 and 2018. Medicare continues to perform well, recognizing that HUM 2018 MA reimbursement could be impacted by a reduction in its star ratings. With about 6% downside to our target price, our rating is Neutral." (2/6/2017)

Who are some of Humana's key competitors?

Who owns Humana stock?

Humana's stock is owned by a variety of of institutional and retail investors. Top institutional investors include CAPITAL WORLD INVESTORS (10.10%), BlackRock Inc. (8.30%), Vanguard Group Inc. (6.52%), State Street Corp (4.35%), Glenview Capital Management LLC (3.68%) and FMR LLC (3.38%). Company insiders that own Humana stock include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge and Timothy S Huval. View Institutional Ownership Trends for Humana.

Who sold Humana stock? Who is selling Humana stock?

Humana's stock was sold by a variety of institutional investors in the last quarter, including Glenview Capital Management LLC, Marshall Wace LLP, OppenheimerFunds Inc., Morgan Stanley, State of New Jersey Common Pension Fund D, Public Employees Retirement Association of Colorado, OZ Management LP and ING Groep NV. Company insiders that have sold Humana stock in the last year include Brian P Leclaire, Bruce D Broussard, Cynthia H Zipperle, David A Jr/Ky Jones, James E Murray, Jody L Bilney, M Todoroff Christopher, Roy A Beveridge and Timothy S Huval. View Insider Buying and Selling for Humana.

Who bought Humana stock? Who is buying Humana stock?

Humana's stock was bought by a variety of institutional investors in the last quarter, including BlackRock Inc., FMR LLC, Renaissance Technologies LLC, Wellington Management Group LLP, AQR Capital Management LLC, MARSHALL WACE ASIA Ltd, Marshall Wace North America L.P. and Sachem Head Capital Management LP. View Insider Buying and Selling for Humana.

How do I buy Humana stock?

Shares of Humana can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Humana stock cost?

One share of Humana stock can currently be purchased for approximately $232.23.

Analyst Ratings

Consensus Ratings for Humana (NYSE:HUM) (?)
Ratings Breakdown: 8 Hold Ratings, 10 Buy Ratings
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $212.73 (8.40% downside)

Analysts' Ratings History for Humana (NYSE:HUM)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/10/2017Deutsche Bank AGLower Price TargetHold$234.00 -> $216.00LowView Rating Details
5/4/2017Jefferies Group LLCReiterated RatingHold$221.00 -> $230.00HighView Rating Details
4/26/2017Cantor FitzgeraldBoost Price TargetNeutral$190.00 -> $200.00LowView Rating Details
4/25/2017Evercore ISIReiterated RatingOutperform$240.00LowView Rating Details
4/25/2017Cowen and CompanyReiterated RatingOutperform$230.00LowView Rating Details
3/30/2017CIBCReiterated RatingOutperformLowView Rating Details
3/30/2017Oppenheimer Holdings Inc.Initiated CoverageOutperform -> Outperform$236.00 -> $236.00LowView Rating Details
2/10/2017Royal Bank of CanadaReiterated RatingHold$207.00N/AView Rating Details
1/27/2017Bank of America CorpInitiated CoverageBuyN/AView Rating Details
1/24/2017Stifel NicolausDowngradeBuy -> Hold$214.00 -> $210.00N/AView Rating Details
1/18/2017ArgusReiterated RatingHoldN/AView Rating Details
1/9/2017Barclays PLCReiterated RatingHold$217.00N/AView Rating Details
1/3/2017Piper Jaffray CompaniesInitiated CoverageOverweight$231.00N/AView Rating Details
12/4/2016Susquehanna Bancshares IncReiterated RatingNeutral$180.00 -> $200.00N/AView Rating Details
11/11/2016Credit Suisse Group AGUpgradeNeutral -> Outperform$175.00 -> $210.00N/AView Rating Details
11/10/2016JPMorgan Chase & Co.UpgradeNeutral -> Overweight$163.00 -> $202.00N/AView Rating Details
7/22/2016FBR & CoLower Price TargetMkt Perform$220.00 -> $170.00N/AView Rating Details
7/21/2016Wolfe ResearchUpgradeOutperform$192.00N/AView Rating Details
6/21/2016Leerink SwannReiterated RatingOutperformN/AView Rating Details
5/22/2016Morgan StanleyReiterated RatingHoldN/AView Rating Details
7/6/2015WedbushDowngradeOutperform -> Neutral$230.00N/AView Rating Details
6/3/2015Sterne Agee CRTUpgradeUnderperform -> NeutralN/AView Rating Details
(Data available from 5/25/2015 forward)


Earnings History for Humana (NYSE:HUM)
Earnings by Quarter for Humana (NYSE:HUM)
Earnings History by Quarter for Humana (NYSE:HUM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/3/2017Q1 2017$2.55$2.75$13.61 billion$13.76 billionViewN/AView Earnings Details
2/8/2017Q416$2.05$2.09$13.55 billion$12.88 billionViewN/AView Earnings Details
11/4/2016Q316$3.09$3.18$13.41 billion$13.69 billionViewN/AView Earnings Details
8/3/2016Q216$2.23$2.30$13.59 billion$14.00 billionViewN/AView Earnings Details
5/4/2016Q1$1.81$1.86$13.80 billion$13.80 billionViewN/AView Earnings Details
2/10/2016Q415$1.45$1.45$13.51 billion$13.40 millionViewN/AView Earnings Details
11/6/2015Q315$2.13$2.16$13.64 billion$13.36 billionViewN/AView Earnings Details
7/29/2015Q215$1.63$1.67$13.81 billion$13.73 billionViewN/AView Earnings Details
4/29/2015Q115$2.54$2.47$13.51 billion$13.80 billionViewListenView Earnings Details
2/4/2015Q414$1.16$1.09$12.41 billion$12.23 millionViewListenView Earnings Details
11/7/2014Q314$2.01$1.85$12.34 billion$12.24 billionViewListenView Earnings Details
7/30/2014Q214$2.19$2.19$11.93 billion$12.22 billionViewListenView Earnings Details
5/7/2014Q114$1.94$2.35$11.45 billion$11.71 billionViewListenView Earnings Details
2/5/2014Q413$0.95($0.19)$10.23 billion$10.20 billionViewListenView Earnings Details
11/6/2013Q313$2.14$2.31$10.27 billion$10.00 billionViewListenView Earnings Details
7/31/2013Q2 2013$2.46$2.63$10.36 billion$10.32 billionViewListenView Earnings Details
5/1/2013Q1 2013$1.80$2.95$10.23 billion$10.49 billionViewListenView Earnings Details
2/4/2013Q4 2012$1.07$1.19$9.73 billion$9.56 billionViewListenView Earnings Details
11/5/2012Q312$2.05$2.62$9.86 billion$9.65 billionViewN/AView Earnings Details
7/30/2012$2.21$2.16ViewN/AView Earnings Details
4/30/2012$1.54$1.49ViewN/AView Earnings Details
2/6/2012$1.20$1.20ViewN/AView Earnings Details
10/31/2011$2.03$2.54ViewN/AView Earnings Details
8/1/2011$2.05$2.50ViewN/AView Earnings Details
5/2/2011$1.86$1.86ViewN/AView Earnings Details
2/7/2011$0.81$0.63ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Humana (NYSE:HUM)
2017 EPS Consensus Estimate: $10.69
2018 EPS Consensus Estimate: $13.58
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20174$2.07$2.75$2.36
Q2 20174$2.37$3.29$3.00
Q3 20174$3.15$3.44$3.26
Q4 20174$1.77$2.56$2.08
Q1 20181$2.95$2.95$2.95
Q2 20181$3.41$3.41$3.41
Q3 20181$3.61$3.61$3.61
Q4 20181$3.61$3.61$3.61
(Data provided by Zacks Investment Research)


Current Dividend Information for Humana (NYSE:HUM)
Next Dividend:7/31/2017
Annual Dividend:$1.16
Dividend Yield:0.50%
Dividend Growth:3.10% (3 Year Average)
Payout Ratio:29.59% (Trailing 12 Months of Earnings)
10.41% (Based on This Year's Estimates)
9.57% (Based on Next Year's Estimates)
Track Record:6 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for Humana (NYSE:HUM)

Dividend History by Quarter for Humana (NYSE:HUM)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for Humana (NYSE:HUM)
Insider Ownership Percentage: 0.50%
Institutional Ownership Percentage: 93.00%
Insider Trades by Quarter for Humana (NYSE:HUM)
Institutional Ownership by Quarter for Humana (NYSE:HUM)
Insider Trades by Quarter for Humana (NYSE:HUM)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/5/2017Jody L BilneySVPSell4,600$230.16$1,058,736.00View SEC Filing  
5/4/2017Bruce D BroussardCEOSell118,231$225.82$26,698,924.42View SEC Filing  
5/4/2017Timothy S HuvalVPSell13,939$225.86$3,148,262.54View SEC Filing  
3/21/2017Jody L BilneySVPSell4,348$213.80$929,602.40View SEC Filing  
3/6/2017James E MurrayCOOSell31,151$213.62$6,654,476.62View SEC Filing  
3/3/2017Cynthia H ZipperleVPSell1,885$213.37$402,202.45View SEC Filing  
2/24/2017Brian P LeclaireSVPSell4,971$204.81$1,018,110.51View SEC Filing  
2/22/2017Brian P LeclaireSVPSell26,894$205.24$5,519,724.56View SEC Filing  
2/22/2017James E MurrayCOOSell9,523$204.69$1,949,262.87View SEC Filing  
2/22/2017Roy A BeveridgeVPSell4,832$205.73$994,087.36View SEC Filing  
2/21/2017Bruce D BroussardCEOSell104,256$205.23$21,396,458.88View SEC Filing  
2/21/2017Cynthia H ZipperleCAOSell4,213$204.67$862,274.71View SEC Filing  
2/21/2017David A. Jr/Ky JonesDirectorSell27,000$205.04$5,536,080.00View SEC Filing  
2/21/2017James E MurrayCOOSell70,332$205.20$14,432,126.40View SEC Filing  
2/21/2017Jody L BilneySVPSell6,087$204.72$1,246,130.64View SEC Filing  
2/21/2017M Todoroff ChristopherVPSell24,140$205.33$4,956,666.20View SEC Filing  
2/25/2016Brian P LeclaireSVPSell183$176.11$32,228.13View SEC Filing  
3/11/2015James E MurrayCOOSell35,220$160.90$5,666,898.00View SEC Filing  
3/2/2015Brian P LeclaireSVPSell5,500$161.79$889,845.00View SEC Filing  
2/25/2015Bruce D BroussardCEOSell41,105$165.29$6,794,245.45View SEC Filing  
2/25/2015David A Jr/Ky JonesDirectorSell6,100$165.39$1,008,879.00View SEC Filing  
2/24/2015Heidi S MargulisVPSell3,665$164.44$602,672.60View SEC Filing  
8/22/2014Brian P LeclaireSVPSell3,250$123.04$399,880.00View SEC Filing  
5/15/2014Heidi MargulisVPSell3,345$119.56$399,928.20View SEC Filing  
5/12/2014Marissa PetersonDirectorSell2,026$123.30$249,805.80View SEC Filing  
3/19/2014James MurrayCOOSell36,833$116.59$4,294,359.47View SEC Filing  
3/18/2014M Todoroff ChristopherVPSell8,000$113.20$905,600.00View SEC Filing  
3/13/2014Bruce BroussardCEOSell109,000$109.84$11,972,560.00View SEC Filing  
3/10/2014Webster Roy DunbarDirectorSell9,587$110.30$1,057,446.10View SEC Filing  
12/4/2013Marissa PetersonDirectorSell1,147$103.54$118,760.38View SEC Filing  
12/2/2013M Todoroff ChristopherVPSell6,000$105.50$633,000.00View SEC Filing  
11/26/2013Heidi MargulisVPSell5,500$104.42$574,310.00View SEC Filing  
11/8/2013David Jr/Ky JonesDirectorSell11,000$95.00$1,045,000.00View SEC Filing  
9/5/2013Elizabeth D BierbowerInsiderSell17,673$96.01$1,696,784.73View SEC Filing  
8/30/2013Heidi MargulisVPSell3,319$93.35$309,828.65View SEC Filing  
8/29/2013David Jr/Ky JonesDirectorSell2,500$93.01$232,525.00View SEC Filing  
8/23/2013Elizabeth BierbowerInsiderSell6,063$94.00$569,922.00View SEC Filing  
8/15/2013Michael MccallisterDirectorSell138,817$91.49$12,700,367.33View SEC Filing  
8/13/2013Bruce PerkinsInsiderSell9,000$93.47$841,230.00View SEC Filing  
8/8/2013Steven McculleyVPSell10,000$92.54$925,400.00View SEC Filing  
8/7/2013James BloemCFOSell33,000$91.79$3,029,070.00View SEC Filing  
8/1/2013M Todoroff ChristopherVPSell39,596$90.30$3,575,518.80View SEC Filing  
6/24/2013Paul B K KusserowSVPSell34,219$84.60$2,894,927.40View SEC Filing  
6/18/2013Elizabeth D BierbowerInsiderSell8,033$83.29$669,068.57View SEC Filing  
5/30/2013James E MurrayCOOSell11,000$81.96$901,560.00View SEC Filing  
5/9/2013Michael B MccallisterDirectorSell281,312$77.72$21,863,568.64View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for Humana (NYSE:HUM)
Latest Headlines for Humana (NYSE:HUM)
DateHeadline logoInsurers continue to hike prices, abandon ACA markets - May 25 at 10:41 AM logoHumana Inc (HUM) Rating Increased to Buy at Zacks Investment Research - May 25 at 10:08 AM logoThe World Bank Group's executive director has a stern war... - May 24 at 10:40 PM logoAnthem weighing 2018 Obamacare individual participation by state - May 24 at 11:41 AM logoZacks Investment Research Downgrades Humana Inc (HUM) to Hold - May 23 at 1:52 PM logoHumana Inc (HUM) Receives Average Rating of "Buy" from Brokerages - May 23 at 8:11 AM logoUniversal Health (UHS) Receives Rating Action from Moody's - May 22 at 10:58 AM logoHumana: Lower Share Price Ahead - May 22 at 10:58 AM logoThe 'single most destabilizing factor' facing Obamacare and premiums has health insurers sweating - May 22 at 10:58 AM logoHumana Honors 15 National Senior Games Athletes Who Inspire People of All Ages to Achieve Their Best Health - Business Wire (press release) - May 19 at 5:32 PM logoStocks In A Buy Zone: Managed Care Leader Humana Gets Rating Upgrade - May 19 at 10:18 AM logoHumana Honors 15 National Senior Games Athletes Who Inspire People of All Ages to Achieve Their Best Health - May 19 at 10:18 AM logoZacks Investment Research Upgrades Humana Inc (HUM) to "Buy" - May 18 at 12:30 PM logoPost Earnings Coverage as Humana's EPS Surged 38%; Adjusted Revenue Gained 4% - May 17 at 10:05 AM
News IconBRIEF-Omega Advisors ups share stake in Alphabet, Facebook, Zynga, Time Inc - May 16 at 5:40 PM logoWhat it means for most Americans when insurers bail on Obamacare - May 13 at 5:27 PM logoWhy Aetna pulling out doesn't mean Obamacare is imploding - May 13 at 5:27 PM logoBlog Coverage: Obamacare Receives Another Jolt as Health Insurer Aetna Announces Withdrawal from all Current Affordable Care Act Exchanges - May 12 at 6:26 PM logoAetna Inc. (AET) Won’t Participate in Any Obamacare Exchanges in 2018 - May 11 at 6:23 PM logoDelaware Judge Allows Cigna to Escape Anthem Deal - May 11 at 6:23 PM logoMore price hikes likely for government insurance markets - May 11 at 3:07 PM logoAetna fully exits Obamacare exchanges with pull-out in 2 states - May 10 at 11:29 PM logoHumana Inc (HUM) Rating Reiterated by Deutsche Bank AG - May 10 at 8:21 PM logoHumana Inc. to Present at Bank of America Merrill Lynch 2017 Health Care Conference - May 10 at 6:27 PM logoHumana Brings Value-Based Orthopedic Specialty Care to North Carolina and Virginia - May 10 at 1:27 PM logoAn insurer just stepped in to save Tennessee's Obamacare market from disaster - May 9 at 5:34 PM logoTennessee insurer could fill Knoxville Obamacare void, but warns of higher prices due to GOP moves - May 9 at 5:34 PM logoHumana hiring telesales positions in Phoenix - May 9 at 5:34 PM logoHumana Inc (HUM) SVP Jody L. Bilney Sells 4,600 Shares - May 9 at 4:37 PM logoHumana Inc (HUM) Lifted to Buy at Zacks Investment Research - May 8 at 7:11 PM logoHumana Inc Forecasted to Post Q2 2017 Earnings of $3.16 Per Share (HUM) - May 8 at 8:21 AM logoOppenheimer Holdings Comments on Humana Inc's Q2 2017 Earnings (HUM) - May 8 at 8:21 AM logoHumana Inc (HUM) Forecasted to Earn Q2 2017 Earnings of $3.29 Per Share - May 8 at 8:15 AM logoEdited Transcript of HUM earnings conference call or presentation 3-May-17 1:00pm GMT - May 5 at 5:45 PM logoHumana CEO's stock moves nets him millions - May 5 at 5:45 PM logoInsiders Sell Amazon, Humana, MasterCard - May 5 at 5:45 PM logoBrokers Set Expectations for Humana Inc's Q3 2017 Earnings (HUM) - May 5 at 11:19 AM logoJefferies Group Analysts Reduce Earnings Estimates for Humana Inc (HUM) - May 5 at 11:19 AM logoTimothy S. Huval Sells 13,939 Shares of Humana Inc (HUM) Stock - May 5 at 8:10 AM logoHumana Inc (HUM) CEO Bruce D. Broussard Sells 118,231 Shares - May 5 at 8:08 AM logoBRIEF-Humana inc qtrly GAAP revenue $13.76 billion versus $13.80 billion - Reuters - May 4 at 10:59 PM logoBRIEF-Humana Inc says "initial indications of Medicare premium levels are also encouraging" - Reuters - May 4 at 10:59 PM logoIf The Senate Doesn't Fix The House's Obamacare Replacement, The GOP Will Pay A Steep Price - May 4 at 10:59 PM logoHumana (HUM) Q1 2017 Results - Earnings Call Transcript - May 4 at 5:57 PM logoHumana Inc (HUM) Rating Reiterated by Jefferies Group LLC - May 4 at 1:20 PM logoCompany News for May 04, 2017 - May 4 at 12:24 PM logoAnalysts Set Humana Inc (HUM) Target Price at $212.13 - May 4 at 1:31 AM logoOuster Of Molina Family May Be Bad For Insurer's 1M Obamacare Patients - May 3 at 10:03 PM logoHumana Inc (HUM) Announces Quarterly Earnings Results, Hits Expectations - May 3 at 8:00 PM logoHumana Inc Announces 32% Advance In Q1 Profit - May 3 at 5:01 PM



Humana (HUM) Chart for Thursday, May, 25, 2017

This page was last updated on 5/25/2017 by Staff